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INTRODUCTION
Endoscopic mucosal resection (EMR) is regarded as a safe and 
effective treatment for large sessile colorectal polyps (20 mm or 
more),1 nevertheless, it remains challenging because of techni-
cal difficulties, the high risk of complications, and the potential 
of coexisting malignancies or local recurrence following the 
procedure.2-5 A recent multicenter study showed favorable out-
come success rate of 89.2% for a single session EMR; complica-
tions were observed in 7.7% of cases, including post-procedure 
pain in 2.1%, serositis in 1.5%, bleeding in 2.9% of patients, and 
perforation in 1.3% of patients.6
Regardless of the EMR technical advances, which have re-
sulted in these favorable results, the long-term outcomes have 
not been elucidated, especially for large sessile colorectal pol-
yps. The large colorectal polyp local recurrence rate following 
EMR has been reported to be between 5% and 45%,2,3,7 although 
it is difficult to compare the results from these different studies 
because of a wide variation in the polyp size, EMR method, and 
follow-up interval. A recent multicenter study reported a 20.4% 
of local recurrence or residual tumor presence detected using 
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surveillance colonoscopy.6 In regard to the technical aspects of 
resection, en bloc resection of lesions is recommended because 
it allows for a more accurate histological assessment and re-
duces the risk of local recurrence.8,9 However, in cases where 
difficult locations or large polyp sizes prevent en bloc resection, 
endoscopic piecemeal mucosal resection (EPMR) is recom-
mended.10 EPMR is regarded as a significant risk factor for local 
recurrence, especially in cases where 5 or more neoplasm speci-
mens are removed.11 Thus, in cases of EPMR, short interval fol-
low-up colonoscopy is recommended, irrespective of the tu-
mor size or macroscopic features.11
According to several current guidelines,12-15 a repeat colonos-
copy is recommended after a short interval (2–6 months) be-
cause of high rate of local recurrence and residual tumor pres-
ence, especially in patients with large sessile adenomas removed 
by piecemeal resection. However, this advice is based on expert 
opinion; there is no definitive evidence for short interval colo-
noscopy in such high-risk adenoma cases. Therefore, a consen-
sus needs to be reached regarding the best surveillance colo-
noscopy interval following EMR for large sessile colorectal 
polyps. The aim of this study was to evaluate the long-term out-
comes and elucidate the best surveillance colonoscopy interval 
following EMR of large sessile colorectal polyps.
MATERIALS AND METHODS
Patients and study protocol
Our colonoscopy cohort included 331 consecutive patients 
who received endoscopic treatment for colorectal polyps larger 
than 20 mm from May 2005 to November 2011 at Yonsei Uni-
versity College of Medicine, Seoul, Korea. Patients were includ-
ed if the following polyp criteria were met: 1) sessile polyp (de-
fined as a lesion in which the base is attached to the colon wall) 
or flat polyp (defined as a lesion with a thickness less than half 
of the maximum width); 2) equal to or greater than 20 mm in 
size; and 3) adenoma, carcinoma in situ, or intramucosal can-
cer indicated in the final pathological report following endo-
scopic resection.16 We excluded patients with colorectal tumors 
with stalks, colorectal cancers, carcinoids, a non-neoplastic his-
tology, or patients without a follow-up colonoscopy. Among the 
331 consecutive patients, a total of 127 patients were excluded 
for the following reasons: pedunculated type (n=28), colorectal 
cancer (n=73), carcinoid (n=5), non-neoplastic histology (n=4), 
and no record of follow-up colonoscopy (n=17). Finally, 204 
patients with sessile and flat-type colorectal polyps larger than 
20 mm were included in the study (Fig. 1). Clinical, endoscopic, 
and demographic data were extracted from computerized clini-
cal information system and reviewed retrospectively. The study 
was approved by the Institutional Review Board of our hospital. 
All study procedures were conducted in accordance with the In-
ternational Conference on Harmonisation Good Clinical Prac-
tices and the Declaration of Helsinki and its amendments.
Procedures
Colonoscopies were performed after bowel preparation with 4 
L polyethylene glycol solution (Colyte; Taejun, Seoul, Korea or 
Colyte-F or Colonlyte; Dreampharma, Seoul, Korea), by using a 
single-channel high definition colonoscope (CF Q240L, CF 
Q240I, CF H260AI, CF Q260AI, or PCF Q260AI; Olympus Opti-
cal Co., Tokyo, Japan) and a high-frequency generator with an 
automatically controlled system (VIO300; ERBE Elektromedizin 
GmbH, Tubingen, Germany). A translucent cap (D-201-13404 
or D-201-14304; Olympus, Optical Co., Ltd., Tokyo, Japan) was 
mounted on the tip of the colonoscope to control the depth of 
the mucosal incision and to maintain a satisfactory view during 
the submucosal dissection.17 Procedures were performed with 
a patient in a left lateral position under monitored anesthesia 
sedation. All procedures were performed by 4 experienced gas-
troenterologists. The endoscopic treatments, including EMR or 
endoscopic submucosal dissection (ESD), were decided ac-
cording to the characteristics of the lesion and the preference of 
operators. EMR was performed using a snare after injecting a 
solution (normal saline, indigo carmine 0.04%, with or without 
1:100000 dilution of epinephrine) into the submucosa.18 Se-
quential submucosal injection and snare polypectomies were 
performed for tumor remnants.11 For EMR or snare polypecto-
mies, RotaSnare® (Oval shape, 15/25/35 mm sized; manufac-
tured by Medi-Globe GmbH) was used. ESD was performed 
with a flex knife (Flex Knife; KD-630L, Olympus, Optical Co., 
Ltd.) or a dual knife (Dual Knife; KD-650L, Olympus, Optical 
Co., Ltd.). After spraying and injecting 0.4% indigo carmine dye 
solution into the submucosa beneath the lesion, a circumferen-
tial incision was made with a flex knife set to approximately 2 
mm in length. After an additional injection beneath the lesion, 
the submucosal layer was dissected directly using the flex knife 
set to approximately 1 mm in length or the dual knife19 to lift it 
away from the muscularis propria sufficiently. If a residual le-
sion was detected endoscopically, additional EMR was per-
formed. Resections were defined as follows; en bloc resection 
was a single piece resection and piecemeal resection was a 
multiple fragment resection.20 We did not routinely apply argon 
plasma coagulation or hot biopsy when the post-procedure site 
was clean. We applied hot biopsy only when the remnant lesion 
was suspected endoscopically.
Pathological evaluation
Specimens were collected using a basket or by aspiration into 
the suction channel. For the retrieval of entire sessile polyps lo-
cated in the right colon, the colonoscope was withdrawn and re-
inserted as many times as necessary. All specimens were cut 
into 2–2.5 mm slices and examined microscopically for differ-
entiation, lymphatic invasion, vascular involvement, depth of 
invasion, the lateral (mucosal) resection margin, and the basal 
(submucosal) resection margin. The extension of tumor cells to 
the resected margin was evaluated and graded as complete re-
section when the lateral and basal resection margins were free 
http://dx.doi.org/10.3349/ymj.2016.57.5.11061108
Endoscopic Treatment Outcome for Large Polyps
of tumor (en bloc resection is essential), incomplete resection 
when the tumor extended into the lateral or basal margins, or 
not evaluable when the margins were not evaluable as a result 
of the artificial effects of coagulation necrosis or multipiece re-
section.21 We defined negative margin involvement as instances 
where both lateral mucosal margins of a specimen were free of 
neoplastic cells. All tumors had negative basal margins. Fur-
thermore, 2 grades of dysplasia (high and low) were recognized. 
The terms “carcinoma in situ” and “intramucosal adenocarci-
noma” were both described as high-grade dysplasia.22
Definition and follow-up
Right-sided colon tumors were defined as those arising from 
the cecum to the transverse colon. Left-sided colon tumors 
were defined as those arising from the splenic flexure down to 
and including the rectosigmoid junction. Rectal tumors were 
defined as those arising distal to the rectosigmoid junction 
down to the anus (excluding squamous cell carcinoma).23,24 
Postprocedural bleeding (PPB) was divided into immediate 
PPB (IPPB) and delayed (DPPB). IPPB was defined as bleeding 
observed immediately after polypectomy and required hemo-
static procedures because the bleeding continued for over 60 s. 
DPPB was defined as bleeding that occurred at the polypecto-
my site within 30 days of the procedure and required hospital-
ization or treatment.25 Other delayed adverse events of each pa-
tients were collected at the out-paitent clinics.
Patients were followed-up with colonoscopy to evaluate re-
currence and residual tumor presence. The interval of surveil-
lance colonoscopy was decided according to the previous guide-
lines26 and recommendations of our institution. Prior to 2009, 
however, surveillance colonoscopy was usually recommended 
after a short interval of less than 12 months. After 2009, surveil-
lance colonoscopy was recommended 12 months after initial 
treatment, even in cases of piecemeal resection or ESD. If a pol-
yp was detected in follow-up examinations, it was resected if 
possible. Local recurrence was defined as the presence of ade-
nomatous or carcinomatous tissue on follow-up, confirmed by 
histology, at the site of prior endoscopic treatment.27 When the 
local recurrence was suspected, endoscopical mucosal resec-
tion was initially tried. If endoscopical treatment was not suffi-
cient, additional surgical treatment was applied.
Statistical analysis
Descriptive statistics are provided for the binary and continuous 
variables using the incidence frequency (%) and mean±standard 
deviation [or median (and range) values]. The chi-square test 
and Fisher’s exact test were used to compare binary variables, 
and the two-sample t-test was used to compare continuous vari-
ables. Multivariate logistic regression analysis, adjusted by con-
founding factors, was performed to discern the contribution of 
variable factors to inter-group differences in local recurrence (no 
recurrence vs. recurrence). Two-sided p-values were calculated 
and significance was accepted at the 5% level. All of the statisti-
cal analyses were performed with Predictive Analytics SoftWare 
for Windows, version 18.0.0 (SPSS Inc., Chicago, IL, USA).
Fig. 1. Flow chart of patients throughout the study. We excluded colorectal tumors with stalks, colorectal cancers, carcinoids, tumors with a non-neoplas-
tic histology, or patients without follow-up colonoscopy. Among the 331 consecutive patients, a total of 127 patients were excluded for the following rea-
sons: pedunculated type (n=28), colorectal cancer (n=73), carcinoid (n=5), non-neoplastic histology (n=4), and no record of follow-up colonoscopy (n=17). 
Colonoscopy cohort of 331 consecutive patients with colorectal polyps
1) Sessile polyp or flat polyp
2) Size equal to or greater than 20 mm
3) Adenoma, carcinoma in situ, or intramucosal cancer 
    on pathological results after ER
127 patients were excluded
Pedunculated type (n=28)
Colorectal cancer (n=73)
Carcinoid (n=5)
Non-neoplastic histology (n=4)
Np record of follow-up (n=17)
204 patients were included
Surveillance colonoscopy short-interval
n=110 (53.9%)
Surveillance colonoscopy long-interval
n=94 (46.1%)
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RESULTS
Patient characteristics and clinical outcomes 
at surveillance colonoscopy
The baseline clinical, endoscopic, and pathological characteris-
tics are summarized in Table 1. Among the 204 patients, there 
were 128 (62.7%) men and the mean age was 65.1 years. The 
mean follow-up duration was 44.2±29.5 months. There were 144 
flat (70.6%) and 60 sessile polyps (29.4%). The median tumor 
size was 25 mm. Among the 204 patients, 194 (95.1%) patients 
were treated with EMR and 10 patients (4.9%) were treated with 
ESD. The en bloc resection rate was 62.3%, and 77 patients 
(37.7%) received piecemeal resections. A negative resection 
margin was observed in 167 cases (81.9%), and 37 cases (18.1%) 
had a positive lateral margin. Low-grade dysplasia was ob-
served in 100 cases (49%), and high-grade dysplasia was ob-
served in 104 cases (51%). IPPB occurred in 65 patients (31.9%); 
59 cases of these occurred during EMR and 6 occurred during 
ESD. All bleeding was successfully treated using endoscopic 
hemostasis. There was no case of DPPB. Perforations devel-
oped in 4 patients (2.0%); all of these patients were in the EMR 
group and were successfully treated with clipping.
The median surveillance colonoscopy interval was 9.4 months 
(1–66 months). A short interval surveillance colonoscopy, with 
a median of 6.3 months and range of 1–11 months, occurred in 
110 patients (53.9%), and 94 patients (46.1%) received a long in-
terval surveillance colonoscopy with a median of 13.6 months 
and range of 12–66 months. Piecemeal resection patients tend-
ed to receive short interval colonoscopies compared to en bloc 
resection patients (66.2% vs. 46.5%, respectively; p=0.006). 
There were no significant differences in the colonoscopy inter-
val for patients with different treatment methods (p=0.112), 
margin statuses (p=0.150), or histologies (p=0.068).
During the surveillance colonoscopy, 14 local recurrences 
(6.9%) were detected. The mean follow-up duration was 47.6± 
25.3 months in 14 patients with recurrence and 43.9±29.9 
months in 190 patients without recurrence (p=0.606). Further 
details of the patients with local recurrence are given in Table 2. 
Of the local recurrence patients, 7 were located on the right side 
of the colon. There were 4 patients with sessile-type and 10 pa-
tients with flat-type polyps. Three patients developed local re-
currences even after an initial en bloc resection with negative 
resection margin. Mean time to recurrence was 28.4 months 
(22.7 months with range of 4–54 months in short surveillance 
interval group vs. 42.8 months with range of 12–82 months in 
long surveillance interval group, p=0.240). Mean size of recur-
rent lesion was 14.6 mm (11.7 mm in short surveillance interval 
group vs. 21.8 mm in long surveillance interval group, p=0.054). 
There were 11 patients who were successfully treated with a 
second endoscopic resection, and 3 patients received surgery.
Risk factors for local recurrence
The potential risk factors for local recurrence are shown in Ta-
ble 3. In addition, we also assessed the effect of the surveillance 
colonoscopy interval on local recurrence. Using multivariate 
analysis, a polyp size greater than 40 mm was shown to be a sig-
nificant risk factor for the detection of local recurrence at sur-
veillance colonoscopy [40–50 mm vs. 20–30 mm, odds ratio (OR) 
14.22 with 95% confidence interval (CI) 2.10–96.17; p=0.006; >50 
mm vs. 20–30 mm, OR 24.25 with 95% CI 3.32–176.88; p=0.002]. 
However, location, tumor morphology, the resection method, 
Table 1. Baseline Characteristics of Enrolled Patients 
Characteristics n=204
Follow-up duration (months) 44.2±29.5
Age (yrs) 65.1±8.2
Sex (male) 128 (62.7%)
Morphology
Flat 144 (70.6%)
Sessile 60 (29.4%)
Size (range, mm)
20–29 131 (64.2%)
30–39 40 (19.6%)
40–49 21 (10.3%)
≥50 12 (5.9%)
Site 
Right side 95 (46.6%)
Left side 57 (27.9%)
Rectum 52 (25.5%)
Treatment method
EMR 194 (95.1%)
ESD 10 (4.9%)
Resection
En bloc 127 (62.3%)
Piecemeal 77 (37.7%)
Resection margin
Negative 167 (81.9%)
Positive 37 (18.1%)
Histological grade
LGD 100 (49.0%)
HGD 104 (51.0%)
Complication
Perforation 4 (2.0%)
Bleeding 65 (31.9%)
Surveillance colonoscopy 
Short interval* 110 (53.9%)
Long interval† 94 (46.1%)
Local recurrence
Negative 190 (93.1%)
Positive 14 (6.9%)
EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissec-
tion; LGD, low-grade dysplasia; HGD, high-grade dysplasia.
Categorical variables are presented as n (%) and continuous variables are 
presented as mean±standard deviation. 
*Surveillance colonoscopy within 12 months, †Surveillance colonoscopy after 
12 months.
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resection status, margin status, and tumor grade were not asso-
ciated with local recurrence. Furthermore, the surveillance colo-
noscopy interval had no effect on the rate of local recurrence.
DISCUSSION
The present study has shown that the endoscopic resection of 
large flat and sessile colorectal polyps generally has a favorable 
outcome with 6.9% of local recurrence. Polyp larger than 40 
mm was an independent risk factor for local recurrence.
EMR is an effective and safe method for the treatment of vari-
ous colorectal neoplasms.28 Recently, EMR has become the 
preferred treatment method for large colorectal polyps around 
the world. This might be due to the favorable outcomes of EMR 
and low complication rates which have previously been report-
ed. A recent large prospective study of 799 EMR-treated colorec-
tal lesions larger than 20 mm indicated that 98.8% of patients 
were adenoma-free and did not require surgery 16 months after 
successful EMR.29 The major complication rates were reported 
as 5.1–7.9%.6,30,31 Another recent study reported a 7.9% major 
complication rate, with 6.3% rate of major bleeding and 1.6% 
rate of perforation.30 Most bleeding is intra-procedural minor 
bleeding and is easily managed by endoscopic hemostasis. Al-
though perforation is a serious complication and sometimes re-
quires surgical management, it can be successfully treated with 
Table 3. Univariate and Multivariate Regression Analysis of the Factors Associated with Local Recurrence
No recurrence
(n=190), n (%)
Recurrence
(n=14), n (%)
Univariate Multivariate
p value Odds ratio (95% CI) p value
Age [median (range), yrs] 65 (44–82) 60 (45–81) 0.184 0.97 (0.90–1.05) 0.490
Sex 0.392 0.608 
Male 121 (63.7) 7 (50.0) 1 
Female 69 (36.3) 7 (50.0)  1.39 (0.39–4.97)  
Size (mm) 0.001 
20–29 128 (67.4) 3 (21.4) 1 
30–39 36 (18.9) 4 (28.6) 5.22 (0.99–27.46) 0.051
40–49 18 (9.5)  3 (21.4) 14.22 (2.10–96.17) 0.006
≥50 8 (4.2) 4 (28.6) 24.25 (3.32–176.88) 0.002 
Site* 0.773
Right 87 (45.8) 8 (57.1) 1
Left 54 (28.4)  3 (21.4) 0.32 (0.07–1.54) 0.155
Rectum 49 (25.8) 3 (21.4) 0.29 (0.51–1.66) 0.165
Morphology 1.000  0.708
Flat 134 (70.5) 10 (71.4) 1 
Sessile 56 (29.5) 4 (28.6) 1.32 (0.31–5.58)
Method 0.517  0.544
EMR 181 (95.3) 13 (92.9) 1
ESD 9 (4.7) 1 (7.1) 2.14 (0.18–24.74)
Resection 0.395  0.423 
En bloc 120 (63.2) 7 (50.0) 1 
Piecemeal 70 (36.8) 7 (50.0) 1.70 (0.46–6.27) 
Margin 0.289  0.373
Negative 157 (82.6) 10 (71.4) 1 
Positive 33 (17.4)  4 (28.6) 2.01 (0.43–9.34) 
Grade 0.588  0.840
LGD 92 (48.4) 8 (57.1) 1 
HGD 98 (51.6) 6 (42.9) 0.86 (0.20–3.68) 
Interval† 0.266 0.213
Short 100 (52.6) 10 (71.4) 1 
Long 90 (47.4) 4 (28.6) 0.42 (0.11–1.65) 
EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; LGD, low-grade dysplasia; HGD, high grade dysplasia; CI, confidence interval.
*Right-sided colon adenomas were defined as those arising from the cecum to the transverse colon. Left-sided colon adenomas were defined as those arising from 
the splenic flexure down to and including the rectosigmoid junction. Rectal adenomas were defined as those arising distal to the rectosigmoid junction and down to 
the anus, †Interval refers to the period between the baseline colonoscopy with endoscopic resection and the first surveillance colonoscopy.
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clipping if it is detected during the procedure. In the present 
study, perforations were detected in 4 patients during the pro-
cedure, and these were managed with clipping and medical 
treatment, thus avoiding surgery. Thus, some operator experi-
ence is necessary in order to achieve favorable EMR outcomes 
with large colorectal polyps, and this can be related to the sur-
veillance colonoscopy interval in practice.
Generally, the recommended adequate surveillance colo-
noscopy interval is based on the risk of metachronous neo-
plasms, as predicted by the clinical and histological findings of 
the index colonoscopy.26,32,33 However, for large colorectal pol-
yps, the surveillance colonoscopy interval is decided according 
to the risk of tumor remnants or recurrence. The local recur-
rence rate after EMR has been reported, ranging from 5% to 
45%.2,3,7 The risk of tumor remnants or recurrence is strongly re-
lated to technical factors, such as en bloc resection, the thera-
peutic method, and the endoscopist’s experience.34-37 The en 
bloc resection rate is reported to be 40–70% for large colorectal 
polyps.2,9,17 Previous studies have shown that the local recur-
rence rate after piecemeal resection is significantly higher than 
en bloc resection, irrespective of the tumor size or macroscopic 
features.38 Several current guidelines, recommended a repeat 
colonoscopy after a short interval (2–6 months) in large sessile 
and flat colorectal polyps treated with en bloc resection be-
cause of the difficulty of complete removal.12-15 In view of this, 
some authors preferentially recommend ESD to achieve en 
bloc resection. In a large prospective cohort study, Saito, et al.39 
recently demonstrated that ESD is a feasible technique for 
treating large superficial colorectal tumors because it provides 
a higher en bloc resection rate. In this study, a total of 145 le-
sions were treated with ESD and 228 lesions treated with con-
ventional EMR; there were only 3 cases (2%) of local recurrence 
in the ESD group, but 14% local recurrence in the EMR group. It 
is evident that ESD achieved a higher en bloc resection rate 
than EMR.7 However, ESD needs more operator experience 
and has a higher complication rate than EMR.7 Thus, ESD can-
not be simply applied at primary hospitals treating large colorec-
tal polyps. Furthermore, the present study showed that proper 
endoscopic treatments, including piecemeal resections, can 
achieve low rates of local recurrence.
In our study, among the 4 recurred cases in the long interval 
surveillance colonoscopy group, 3 (75.0%) patients underwent 
salvage surgeries, possibly implying a possibility that the recur-
rent lesions were not detected early enough for endoscopic sal-
vage treatment. However, among the 4 recurred cases, only 2 
cases were detected in the 1st surveillance colonoscopy. There 
were several studies to imply that a short surveillance colonos-
copy interval could miss tumor local recurrence because of 
limited regrowth time. In a study from Japan, 572 colorectal tu-
mors were followed-up 3 and 6 months after endoscopic resec-
tion, and 28 of the 34 lesions with local recurrence were detect-
ed at the first follow-up colonoscopy, while the remaining 6 
lesions were detected at the second or a subsequent colonos-
copy.38 A recent study with follow-up colonoscopy at 3–6 months 
and 12 months showed a 16.4% rate of late recurrence detec-
tion.30 The residual or recurred tumors were treated effectively 
at follow-up colonoscopy. Thus, it seems reasonable to extend 
the surveillance colonoscopy interval up to 12 months to allow 
time for regrowth and reduce the colonoscopy burden. In the 
present study, among 14 recurred patients, 6 cases (42.9%) were 
detected in the 2nd or 3rd colonoscopy. Therefore, the interval 
of a second or third surveillance would also be very important 
to detect recurred lesions. Consequently, a study of the ade-
quate follow-up interval for the 2nd or 3rd surveillance colo-
noscopy seems to be mandatory.
The limitations of our study include its retrospective design, 
and that a number of the practitioners were subject to potential 
bias. The limited sample size also hindered additional analyses 
of major interest, such as a finer stratification of the time since 
endoscopic resection and the separate classification of polyps 
by individual prognostic factors, such as the number of syn-
chronous lesions and morphological type (e.g., granular or 
non-granular type laterally spreading tumors), all of which have 
been found to be strongly related to adenomatous or carcino-
matous recurrence after endoscopic resection. A finer stratifi-
cation of both the time interval and lesion type would be highly 
desirable so that a clearer safe surveillance period could be de-
lineated for different types of polyp. Another drawback of this 
study is the single-center study design, which may limit the ap-
plication of our results to general colonoscopy practice settings. 
Therefore, further multicenter long term studies are needed in 
order to confirm our findings.
In conclusion, endoscopic treatment is safe and effective 
with a favorable long-term outcome for large sessile and flat 
colorectal polyps. Further prospective study is mandatory to 
define an adequate interval of surveillance colonoscopy.
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